dapi has been researched along with losartan potassium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ijäs, P; Karjalainen-Lindsberg, ML; Lindsberg, PJ; Paetau, A; Sairanen, T | 1 |
| Deng, Y; Huang, Y; Li, Y; Sun, H; Yang, J; Yu, X | 1 |
2 other study(ies) available for dapi and losartan potassium
| Article | Year |
|---|---|
Apoptosis dominant in the periinfarct area of human ischaemic stroke--a possible target of antiapoptotic treatments.
Topics: Adult; Aged; Aged, 80 and over; Apoptosis; Autopsy; Brain; Brain Chemistry; Brain Ischemia; DNA Fragmentation; Erythropoietin; Fas Ligand Protein; fas Receptor; Female; Fluorescent Dyes; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Indoles; Male; Membrane Glycoproteins; Microscopy, Fluorescence; Middle Aged; Receptors, Erythropoietin; Tumor Necrosis Factors | 2006 |
Erythropoietin preconditioning suppresses neuronal death following status epilepticus in rats.
Topics: Analysis of Variance; Animals; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; BH3 Interacting Domain Death Agonist Protein; Cell Count; Cell Death; Disease Models, Animal; Drug Interactions; Erythropoietin; In Situ Nick-End Labeling; Indoles; Male; Membrane Proteins; Neurons; Neuroprotective Agents; Pilocarpine; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Status Epilepticus | 2007 |